AHS Cancer Control Alberta: Breast Neoplasms trials

The registry lists 23 Breast Neoplasms studies with AHS Cancer Control Alberta as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 9Phase 3 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Genetic Based Chemotherapy Dosing for Breast Cancer PatientsRecruitingNCT01740271Phase 2
• Prognostic Indicators for Radiation-induced Breast FibrosisTerminatedNCT05031065
• A Research Study to Collect Patient Reported Outcomes Using Electronic SurveysTerminatedNCT04990895Not applicable
• A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast CancerWithdrawnNCT04149444Phase 2
• Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant SettingActive, not recruitingNCT03831178Phase 2
• The Breast Cancer & Physical Activity Level (BC-PAL) Pilot StudyCompletedNCT03564899Not applicable
• Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer TherapyTerminatedNCT02795572Phase 2
• APBI: 27Gy in 5 Fractions for Early Breast CancerStatus unknownNCT02681107Not applicable
• Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer SubjectsCompletedNCT02187289Not applicable
• Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the HeartStatus unknownNCT02052102Phase 2
• Breast Cancer and Exercise Trial in AlbertaCompletedNCT01435005Not applicable
• Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast CancerCompletedNCT01428739Not applicable
• TORI 104 Pre-Surgical DasatinibWithdrawnNCT01410708Phase 2
• Tomosynthesis in Screening MammographyCompletedNCT01086241Not applicable
• A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast CancerTerminatedNCT00771381Phase 2
• Alberta Physical Activity and Breast Cancer Prevention (ALPHA) TrialCompletedNCT00522262Not applicable
• Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast CancerTerminatedNCT00358098
• Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast CarcinomaTerminatedNCT00291304Phase 2
• Trial of Combined Aerobic and Resistance Exercise in Breast Cancer SurvivorsCompletedNCT00249015Phase 3
• Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.CompletedNCT00156806Phase 3
• An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer TreatmentTerminatedNCT00131612
• Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With RadiotherapyWithdrawnNCT00123812
• Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary DissectionTerminatedNCT00123799Phase 2